Showing results (291-300 of 356) with videos related to

Sort By:
Pageof 36
Molecular Neurodegeneration|June 27, 2014
Epigenetic regulation of adult neural stem cells: implications for Alzheimer's diseaseCarlos P Fitzsimons, Emma van Bodegraven, Marijn Schouten, et al.
International Journal of Alzheimer'S Disease|October 19, 2010
Gene-environment interaction research and transgenic mouse models of Alzheimer's diseaseL Chouliaras, A S R Sierksma, G Kenis, et al.
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
Alzheimer'S Research & Therapy|November 30, 2024
Alzheimer's disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathwayKyonghwan Choe, Muhammad Ali, Roy Lardenoije, et al.
Molecular Psychiatry|July 28, 2022
Blood miR-144-3p: a novel diagnostic and therapeutic tool for depressionYentl Y van der Zee, Lars M T Eijssen, Philipp Mews, et al.
Psychological Medicine|May 5, 2026
Clusters of social and substance use-related risks are associated with the duration of untreated psychosisHannah Edelhoff, Jim van Os, Therese van Amelsvoort, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
Schizophrenia Bulletin|February 17, 2021
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network PerspectiveHui Lin Ong, Adela-Maria Isvoranu, Frederike Schirmbeck, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Pageof 36